Transcatheter arterial infusion of gemicitabine for treatment of advanced pancreatic cancer

( views:, downloads: )
Journal Title:
Volume 2, Issue 02, 2002
Key Word:


  • [1]Laack E, Mende T, Durk H, et al. Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer. a phase II trial. Eur J Cancer, 2002,38:654-560
  • [2]Salman HS, Tanaka K, Sparano JA. Phase I/II trial of gemcitabine plus cyclophosphamide in patients with metastatic breast carcinoma previously treated with taxanes. Clin Breast Cancer. 2002, 299-303
  • [3]D'Agostino G, Ferrandina G, Garganese G, et al. Phase I study of gemcitabine and liposomal Doxorubicin in relapsed ovarian cancer, Oncology. 2002,62:110-114
  • [4]张文俊,许国铭,李兆申.胰腺癌167例临床分析.第二军医大学学报,1998,19:497-498
  • [5]Cartwright TH, Cohn A, Varkey JA, et al. Phase II study of oral capecitabine in patients with advanced or metastatic pancreatic cancer. J Clin Oncol, 2002, 20:160-164
  • [6]Huguier M, Barrier A, Valinas R, et al. Randomized trial of 5-luorouracil, leucovorin and cisplatin in advanced pancreatic cancer. Hepatogastroenterology, 2001, 48: 875-878
  • [7]Wolff RA, Evans DB, Gravel DM, et al. Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma. Clin Cancer Res, 2001, 7: 2246-2253
  • [8]Mehta VK, Poen JC, Ford JM, et al. Protracted venous infusion 5-fluorouracil with concomitant radiotherapy compared with bolus 5-fluorouracil for unresectable pancreatic cancer. Am J Clin Oncol, 2001, 24:155-159
  • [9]Furuse J, Maru Y, Yoshino M, et al. Hepatic arterial infusion of 5-fluorouracil for liver metastases from pancreatic carcinoma: results from a pilot study. Hepatogastroenterology, 2001, 48:208-211
  • [10]Klein B, Sadikov E, Mishaeli M, et al. Comparison of 5-FU and leucovorin to gemcitabine in the treatment of pancreatic cancer. Oncol Rep 2000, 7:875-877
  • [11]Von Hoff DD, Goodwin AL, Garcia L. Advances in the treatment of patients with pancreatic cancer: improvement in symptoms and survival time. The San Antonio Drug Development Team. Br J Cancer, 1998,78 Suppl 3:9-13
  • [12]Carmichael J, Fink U, Russell RC, et al. Phase II study of gemcitabine in patients with advanced pancreatic cancer. Br J Cancer, 1996, 73:101-105
  • [13]King RS. Gemcitabine. New first-line therapy for pancreatic cancer. Cancer Pract, 1996: 353-354
  • [14]奚文崎,蒋劲松,楼谷音等.吉西他滨治疗18例胰腺癌疗效和毒副反应分析.胰腺病学, 2002,2:34-37
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615